DEFINITIVE CONTRACT
Active75N93026C00007
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NIAID
$1.5M
obligated · signed 3 months ago
DEVELOPMENT OF RADIATION/NUCLEAR MEDICAL COUNTERMEASURES (MCMS) AND BIODOSIMETRY DEVICES. 7-1/2026 TO 6/30/2026. DAP-NCAP-00000073.
Performance timeline
Start
Jul 1, 2026
Current end
Jun 30, 2027
Potential end
Jun 30, 2029
with all options
Loading status
Estimated start: Jun 30, 2028
CERAMEDIX HOLDING, LLC
Contract 75N93026C00007
UEI
JLZSJRJVKJ49
Parent Company
CERAMEDIX HOLDING, LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 12
Current Obligation
$1,500,000
Base + Exercised Options
$1,500,000
Total Ceiling Value
$4,500,000
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
Congressional District: 10
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Solicitation procedures, competition exceptions, labor standards and account totals.